Qin, L.; Zhou, Y.; Fan, B.; Zheng, J.; Diao, R.; Liu, J.; Wang, F.
Correction: Qin et al. Metabolites from the Dendrobium Endophyte Pseudomonas protegens CM-YJ44 Alleviate Insulin Resistance in HepG2 Cells via the IRS1/PI3K/Akt/GSK3β/GLUT4 Pathway. Pharmaceuticals 2025, 18, 817. Pharmaceuticals 2025, 18, 1234.
https://doi.org/10.3390/ph18081234
AMA Style
Qin L, Zhou Y, Fan B, Zheng J, Diao R, Liu J, Wang F.
Correction: Qin et al. Metabolites from the Dendrobium Endophyte Pseudomonas protegens CM-YJ44 Alleviate Insulin Resistance in HepG2 Cells via the IRS1/PI3K/Akt/GSK3β/GLUT4 Pathway. Pharmaceuticals 2025, 18, 817. Pharmaceuticals. 2025; 18(8):1234.
https://doi.org/10.3390/ph18081234
Chicago/Turabian Style
Qin, Luqi, Yixia Zhou, Bei Fan, Jiahuan Zheng, Rao Diao, Jiameng Liu, and Fengzhong Wang.
2025. "Correction: Qin et al. Metabolites from the Dendrobium Endophyte Pseudomonas protegens CM-YJ44 Alleviate Insulin Resistance in HepG2 Cells via the IRS1/PI3K/Akt/GSK3β/GLUT4 Pathway. Pharmaceuticals 2025, 18, 817" Pharmaceuticals 18, no. 8: 1234.
https://doi.org/10.3390/ph18081234
APA Style
Qin, L., Zhou, Y., Fan, B., Zheng, J., Diao, R., Liu, J., & Wang, F.
(2025). Correction: Qin et al. Metabolites from the Dendrobium Endophyte Pseudomonas protegens CM-YJ44 Alleviate Insulin Resistance in HepG2 Cells via the IRS1/PI3K/Akt/GSK3β/GLUT4 Pathway. Pharmaceuticals 2025, 18, 817. Pharmaceuticals, 18(8), 1234.
https://doi.org/10.3390/ph18081234
